The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacyDaniela Bruni(Inserm), Helen K. Angell(AstraZeneca (United Kingdom)), Jérôme Galon(Inserm)Nature reviews. CancerAugust 4, 202010.1038/s41568-020-0285-7Cited by 1,630SaveCiteExport RISWatch citationsAbstractRelated PapersThe prognostic landscape of genes and infiltrating immune cells across human cancersAndrew J. Gentles, Aaron M. Newman, Chih Long Liu et al.|Nature Medicine|2015|3.2kThe tumour microenvironment after radiotherapy: mechanisms of resistance and recurrenceHolly E. Barker, James Paget, Aadil Khan et al.|Nature reviews. Cancer|2015|2.1kHepatogastroenterologyDong Xu, Xingxing He, Ying Chang et al.|Hepatogastroenterology|2012|2kTowards the introduction of the ‘Immunoscore’ in the classification of malignant tumoursJérôme Galon, Bernhard Mlecnik, Gabriela Bindea et al.|The Journal of Pathology|2013|1.3kReview: Ultraviolet radiation and skin cancerDeevya L. Narayanan, Rao N. Saladi, Joshua Fox|International Journal of Dermatology|2010|1.2k